Mental Health DailyResearch. Evidence. Perspective.Published research on Nootropics.
Recent advancements in neuropharmacology have brought to light S-CE-123, a dopamine transporter inhibitor showing remarkable promise in cognitive enhancement. Its emergence alongside R-modaf…
Read articleAlzheimer’s Disease (AD), a prevalent form of dementia, poses significant challenges for individuals and healthcare systems worldwide. Current treatments primarily offer symptomatic relief w…
Read articleIn the pursuit of peak mental performance, scientific studies have explored the effects of stimulants like methylphenidate, modafinil, and caffeine on cognitive functions such as memory and …
Read articleHydrafinil (Fluorenol) is an unregulated research chemical originally synthesized by Cephalon Pharmaceuticals (now owned by Teva) as a eugeroic (wakefulness-promoting agent). After its synth…
Read articleAdrafinil (Olmifon) is a eugeroic agent originally synthesized in the 1970s by chemists at Group Lafon, a pharmaceutical company based in France. Following its synthesis, researchers discove…
Read articlePhenibut (brand name “Noofen”) is a neuropsychiatric drug originally synthesized in St. Petersburg, Russia by a team of researchers at the Department of Organic Chemistry of the Herzen Pedag…
Read articleNoopept (N-phenylacetyl-L-prolylglycine ethyl ester) is a synthetic peptide manufactured in Russia by JSC LEKKO Pharmaceuticals. Chemically, noopept is a hydrophilic proline with a dipeptide…
Read article
